Search Results - "Alfonso, J. Adeva"

PD-10 Comprehensive circulating tumor (ct) DNA NGS for molecular profiling in advanced cholangiocarcinoma by Visa, L., Sauri, T., Esposito, F., Adeva Alfonso, J., Peinado, P., Ponz-Sarvise, M., Fabregat Franco, C., Carames, C., Salinas, P., Kushnir, M., Macarulla, T., Cubillo, A., Garcia-Carbonero, R., Victoria, I., Bellosillo, B., Montagut, C.

Get full text

1671P Treatment patterns and efficacy in patients (pt) with pancreatic cancer (PC) from the Spanish RETUD registry by Macarulla, T., Munoz Martin, A.J., Martinez de Castro, E., Castillo Trujillo, A.O., Cano Osuna, M.T., Fabregat, C., Vidal Tocino, R., Gallego Plazas, J., Ghanem, I., Ales Diaz, I.C., Vera, R., Lobo de Mena, M., Adeva Alfonso, J., Melian, M., Gallego Jimenez, I., Laquente, B., Fernandez Montes, A., Peinado Martin, P., Carrato Mena, A., Aranda Aguilar, E.

Get full text

Applicability of the LIPI score to metastatic microsatellite instability high cancer patients treated with immune checkpoint inhibitors by Vuagnat, P., Auclin, E., Mezquita, L., Alfonso, J. Adeva, Tocino, M.R. Vidal, Munoz, F. Longo, El Dakdouki, Y., Romano, P. Martin, Baldini, C., Varga, A., Garcia-Carbonero, R., Besse, B., Massard, C., Hollebecque, A.

Get full text

731P - Liver metastases (LM) from intrahepatic cholangiocarcinoma (iCCA): Outcomes from the European Network for the study of cholangiocarcinoma (ENS-CCA) registry and implications on current American Joint Committee on Cancer (AJCC) staging by Lamarca, A., Santos, A., Utpatel, K., La Casta, A., Stock, S., Forner, A., Adeva Alfonso, J., Folseraas, T., Fabris, L., Macias, R., Krawczyk, M., Krawczyk, M., Cardinale, V., Braconi, C., Alvaro, D., Evert, M., Bañales, J., Valle, J.W.

“…The AJCC classifies LM of iCCA as early stage: T2b [stage II/IVa (AJCCv.7) and stage II/III (AJCCv.8) if N0/N1, respectively]; in contrast, LM are perceived by…”
Get full text

Liver metastases (LM) from intrahepatic cholangiocarcinoma (iCCA): Outcomes from the European Network for the study of cholangiocarcinoma (ENS-CCA) registry and implications on current American Joint Committee on Cancer (AJCC) staging by Lamarca, A., Santos, A., Utpatel, K., La Casta, A., Stock, S., Forner, A., Adeva Alfonso, J., Folseraas, T., Fabris, L., Macias, R., Krawczyk, M., Cardinale, V., Braconi, C., Alvaro, D., Evert, M., Bañales, J., Valle, J.W.

Get full text

731PLiver metastases (LM) from intrahepatic cholangiocarcinoma (iCCA): Outcomes from the European Network for the study of cholangiocarcinoma (ENS-CCA) registry and implications on current American Joint Committee on Cancer (AJCC) staging by Lamarca, A, Santos, A, Utpatel, K, La Casta, A, Stock, S, Forner, A, Adeva Alfonso, J, Folseraas, T, Fabris, L, Macias, R, Krawczyk, M, Krawczyk, M, Cardinale, V, Braconi, C, Alvaro, D, Evert, M, Bañales, J, Valle, J W

“…Abstract Background The AJCC classifies LM of iCCA as early stage: T2b [stage II/IVa (AJCCv.7) and stage II/III (AJCCv.8) if N0/N1, respectively]; in contrast,…”
Get full text

2P Lung immune prognostic index (LIPI) can identify the fast-progressor to immune checkpoints inhibitors (ICI) in microsatellite instability (MSI) or mismatch repair deficient (dMMR) tumours by Auclin, E., Vuagnat, P., Smolenschi, C., Taieb, J., Alfonso, J. Adeva, Nebot, L., Garcia de Herreros, M., Tocino, R. Vidal, Longo, F., El Dakdouki, Y., Romano, P. Martin, Alvarez, E. Castanon, Garcia-Carbonero, R., Garcia, L. Gaba, Nadal, T. Sauri, Oliveres, H., Besse, B., Massard, C., Mezquita, L., Hollebecque, A.

Get full text

The role of antiangiogenic therapy in advanced gastro-esophageal cancer: a systematic review and meta-analysis by Riesco-Martinez, M.C., Díaz-Serrano, A., Gomez-Martin, C., Alfonso, J. Adeva, Cabrera, E. Sabater, Garcia-Carbonero, R.

Get full text

Metabolomics in cancer cachexia by Lopez-Martin, J.A., Cala, M., Prieto-García, E., Gonzalez Riano, C., Díaz-García, C.V., García, A., Pardo Marqués, V., Ruperez Pascualena, F., García-Ruiz, I., Pernaut, C., Otero, I., Parrilla Rubio, L., Riesco, M.C., Adeva Alfonso, J., Barbas, C., Agulló-Ortuño, M.T.

Get full text

628PA META-ANALYSIS ON THE EFFICACY OF SECOND LINE (2L) TREATMENT OPTIONS FOR ADVANCED GASTRIC CANCER (AGC) by Riesco Martínez, M.C., Adeva Alfonso, J., Andrés Esteban, E., Gómez-Martín, C., Lema Roso, L., Robles Díaz, L., Parrilla Rubio, L., Ruiz-Ares, G., Pernaut Sánchez, C., López-Martín, J.A.

“…Abstract Aim: Different regimens of systemic chemotherapy (CT) and targeted therapy (TT) have proven to be effective in 2L AGC. No randomized clinical trials…”
Get full text

A Meta-Analysis on the Efficacy of Second Line (2L) Treatment Options for Advanced Gastric Cancer (Agc) by Riesco Martínez, M.C., Adeva Alfonso, J., Andrés Esteban, E., Gómez-Martín, C., Lema Roso, L., Robles Díaz, L., Parrilla Rubio, L., Ruiz-Ares, G., Pernaut Sánchez, C., López-Martín, J.A.

Get full text

Neoadjuvant bevacizumab treatment for colorectal liver metastasis: A retrospective study by García, P., Alvarez, S., Muñoz, A., Lopez, P., Riesco, M., Adeva Alfonso, J., Martin, M.

“…Abstract only 613 Background: Patients with colorectal cancer (CRC) and liver metastases have a poor prognosis and may benefit from perioperative chemotherapy…”
Get full text

Final results of a risk-adapted policy of adjuvant chemotherapy (ACT) in patients with invasive bladder carcinoma (IBC) by Arranz Arija, J. A., Jerez Gilarranz, Y., Soria Lovelle, A., López López, C., Sabin Dominguez, P., Riesco, M. C., Adeva Alfonso, J., Urosa Velasco, D., López Juárez, E., González Beca, R., Martin, M.

“…Abstract only…”
Get full text

Metastatic bladder cancer (MBC) after radical cystectomy and adjuvant chemotherapy compared to MBC after cystectomy by Arranz Arija, J., Jerez Gilarranz, Y., Riesco Martinez, M., Adeva Alfonso, J., González Beca, R., López López, C., Encinas García, S., Soria Lovelle, A., Marquez Rodas, I., Cabezón Gutierrez, L.

“…Abstract only…”
Get full text

Phase II study of neoadjuvant treatment with docetaxel, capecitabine, and trastuzumab in HER-2-positive locally advanced or inflammatory breast cancer: TXH trial by Perez Manga, G., Khosravi-Shahi, P., Izarzugaza Peron, Y., Soria Lovelle, A., Gonzalez del Val, R., Palomero Plaza, M., Riesco Martinez, M., Jerez Gilarranz, Y., Adeva Alfonso, J., Alonso, A.

“…Abstract only e11581 Background: Preoperative chemotherapy(CT) with trastuzumab(H)improves pathologic complete responses(pCR) in patients(ps)with Her-2+locally…”
Get full text

7167 Adjuvant chemotherapy (ACT) in patients with invasive bladder carcinoma (IBC): multivariate analysis of a cohort study by Arija, J.A. Arranz, Beca, R. González, Alvarez, R. Alvarez, López, C. López, Gutiérrez, L. Cabezón, Lovelle, A. Soria, Rodas, I. Márquez, Martínez, M.C. Riesco, Gilarranz, Y. Jerez, Alfonso, J. Adeva

Get full text